We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Innovative Face Mask Inactivates Flu Viruses

By HospiMedica International staff writers
Posted on 03 Apr 2012
An antiviral medical facemask inactivates 99.99% of laboratory tested influenza viruses, including both pandemic and seasonal strains of the flu. More...


The Biofriend BioMask works by using a combination of citric acid, zinc, and copper in different layers of the mask. A hydrophilic coating on the outside quickly wicks droplets into and away from the outer surface. Viruses are inactivated on this outer layer by exposure to citric acid, which creates a low pH environment. The droplet then lands on the mask's inner (blue) layer, where influenza viruses are inactivated by copper and zinc, which are toxic to the pathogens.

Another benefit of the mask is that it can minimize cross contamination. Commonly, the outer facing of the mask is frequently touched by the user, who then touches other things or people; but since the BioMask absorbs infectious droplets and inactivates the viruses, the risk of spreading the virus is greatly reduced. The Biofriend BioMask is a product of Filligent (Hong Kong SAR, China), and has been approved by the US Food and Drug Administration (FDA). It is distributed as the Curad BioMask in the United States, Canada, and Europe by Medline (Mundelein, IL, USA).

“The key difference with the Curad BioMask is that the BioMask inactivates several common strains of viruses when they come in contact with the mask, while viruses that come in contact with standard masks are just filtered, which means they are still active and potentially infectious to the wearer and others,” said Frank Czajka, president of the Proxima Division at Medline. “Whether you are trying to stop from getting the flu or from sharing it with loved ones, you can feel confident of being protected with Medline's Curad BioMask because it is the only mask available today that actively breaks down viruses.”

In independent laboratory tests, the BioMask inactivated 99.99% of tested influenza viruses upon five minutes contact with the surface of the facemask, including influenza A subtypes and strains, H1N1, H3N2, H2N2; avian flu subtypes H5N1, H9N2, H5N2; swine flu subtype H1N1; equine flu subtype H3N8; and Influenza B strains. It is also effective against tuberculosis (TB), rhinovirus, methicillin-resistant Staphylococcus aureus (MRSA), and measles.

Related Links:
Filligent
Medline


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Intelligent Mattress System
DualPlus
New
Multifunctional Patient Floor Lift
Maxi Move 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.